HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Sumerauer Selected Research

Cisplatin (Platino)

1/2020Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Sumerauer Research Topics

Disease

14Neoplasms (Cancer)
01/2022 - 07/2005
5Medulloblastoma
01/2021 - 07/2014
4Glioma (Gliomas)
01/2023 - 01/2020
3Diffuse Intrinsic Pontine Glioma
01/2023 - 01/2017
3Synovial Sarcoma (Synovioma)
08/2009 - 09/2007
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2024 - 01/2021
2Astrocytoma (Pilocytic Astrocytoma)
01/2023 - 01/2020
2Rhabdoid Tumor (Rhabdoid Tumors)
12/2021 - 09/2014
2Neoplasm Metastasis (Metastasis)
01/2018 - 09/2014
1Brain Neoplasms (Brain Tumor)
01/2024
1Meningioma (Meningiomas)
01/2023
1Typical Teratoid Rhabdoid Tumor
01/2022
1Central Nervous System Neoplasms
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
12/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2021
1Necrosis
07/2020
1Ependymoma
01/2020
1Ototoxicity
01/2020
1Genomic Instability
12/2019
1Disease Progression
10/2019
1Turcot syndrome
01/2019
1Circulating Neoplastic Cells
01/2018
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
03/2016
1Sepsis (Septicemia)
03/2016
1Polyneuropathies (Polyneuropathy)
03/2016
1Pancytopenia
03/2016
1Pathologic Complete Response
09/2014
1Sarcoma (Soft Tissue Sarcoma)
08/2009
1Breast Neoplasms (Breast Cancer)
12/2007
1Peripheral Primitive Neuroectodermal Tumors (Peripheral Neuroectodermal Tumor)
11/2002

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2002
3dipinacoline glutamateIBA
01/2023 - 01/2017
2NucleotidesIBA
01/2020 - 12/2019
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2023
1Tuberculin (PPD)IBA
01/2022
1DecitabineFDA Link
12/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Valine (L-Valine)FDA Link
12/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2020
1Histones (Histone)IBA
12/2020
1Arginine (L-Arginine)FDA Link
12/2020
1Bevacizumab (Avastin)FDA Link
07/2020
1N 30IBA
01/2020
1plerixaforFDA Link
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1Phosphotransferases (Kinase)IBA
01/2019
1tyrosine receptor (receptor, tyrosine)IBA
01/2019
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2018
1ChromatinIBA
03/2016
1hydrogen sulfite (bisulfite)IBA
03/2016
1Vincristine (Oncovin)FDA LinkGeneric
03/2016
1Sucrose (Saccharose)IBA
09/2014
1SMARCB1 ProteinIBA
09/2014
1Cyclin D1IBA
08/2009
1oblimersen (G3139)IBA
08/2009
1Messenger RNA (mRNA)IBA
12/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2007
1SYT-SSX fusion proteinIBA
09/2007
1Indicators and Reagents (Reagents)IBA
07/2005
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2002

Therapy/Procedure

8Therapeutics
12/2021 - 08/2007
6Radiotherapy
01/2024 - 01/2020
4Drug Therapy (Chemotherapy)
01/2023 - 07/2014
1Maintenance Chemotherapy
01/2023
1Immunotherapy
01/2022
1Aftercare (After-Treatment)
01/2021
1Cranial Irradiation
01/2021
1Re-Irradiation
07/2020
1Chemoradiotherapy
01/2020
1Hematopoietic Stem Cell Mobilization
01/2020
1Heterologous Transplantation (Xenotransplantation)
01/2018